Publications by authors named "Qin-Yao Zhu"

Diatomic-site catalysts (DACs) garner tremendous attention for selective CO photoreduction, especially in the thermodynamical and kinetical mechanism of CO to C products. Herein, we first engineer a novel Zn-porphyrin/RuCu-pincer complex DAC (ZnPor-RuCuDAC). The heteronuclear ZnPor-RuCuDAC exhibits the best acetate selectivity (95.

View Article and Find Full Text PDF

Background/aims: The function of BRAF V600E as a prognostic biomarker continues controversial by reason of conflicting results in the published articles.

Methods: A systematical literature search for relevant articles was performed in PubMed, Cochrane Library, Google Scholar, Medline and Embase updated to August 5, 2015. The Chi-square test and I2 were employed to examine statistical heterogeneity.

View Article and Find Full Text PDF

Synopsis of recent research by authors named "Qin-Yao Zhu"

  • - Qin-yao Zhu's recent research primarily focuses on catalytic processes and cancer biomarkers, particularly through innovative engineering of diatomic-site catalysts (DACs) for CO photoreduction and analyzing genetic mutations related to thyroid cancer.
  • - In a 2023 study, Zhu developed a novel Zn-porphyrin/RuCu-pincer complex DAC, demonstrating its superior acetate selectivity in C-C coupling, showcasing the potential for enhanced catalyst design in energy conversion applications.
  • - A prior meta-analysis conducted in 2016 on the BRAF(V600E) mutation indicated varying prognostic implications in papillary thyroid carcinoma, emphasizing the need for ongoing investigation into genetic markers and their clinical relevance.